These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 35290415)

  • 1. Identification of miRNA signature for predicting the prognostic biomarker of squamous cell lung carcinoma.
    Liu H; Li T; Dong C; Lyu J
    PLoS One; 2022; 17(3):e0264645. PubMed ID: 35290415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a seven-miRNA signature as prognostic biomarker for lung squamous cell carcinoma.
    Gao X; Wu Y; Yu W; Li H
    Oncotarget; 2016 Dec; 7(49):81670-81679. PubMed ID: 27835574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs associated with lung squamous cell carcinoma: New prognostic biomarkers and therapeutic targets.
    Qi L; Gao C; Feng F; Zhang T; Yao Y; Wang X; Liu C; Li J; Li J; Sun C
    J Cell Biochem; 2019 Nov; 120(11):18956-18966. PubMed ID: 31241205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma.
    Ju Q; Zhao YJ; Ma S; Li XM; Zhang H; Zhang SQ; Yang YM; Yan SX
    J Cancer Res Clin Oncol; 2020 Jul; 146(7):1711-1723. PubMed ID: 32356177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of miR-136-5p key target genes and pathways in lung squamous cell cancer based on TCGA database and bioinformatics analysis.
    Xie ZC; Li TT; Gan BL; Gao X; Gao L; Chen G; Hu XH
    Pathol Res Pract; 2018 May; 214(5):644-654. PubMed ID: 29650443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of Prognostic Model and miRNA-mRNA Regulatory Network for Lung Squamous Cell Carcinoma.
    Zhao L; Fu Q; Shi M; Zhang H
    Altern Ther Health Med; 2024 Feb; 30(2):183-187. PubMed ID: 37856813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A glycolysis-based three-gene signature predicts survival in patients with lung squamous cell carcinoma.
    Huang G; Zhang J; Gong L; Huang Y; Liu D
    BMC Cancer; 2021 May; 21(1):626. PubMed ID: 34044809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of lncRNA biomarkers in lung squamous cell carcinoma using comprehensive analysis of lncRNA mediated ceRNA network.
    Li R; Yang YE; Jin J; Zhang MY; Liu X; Liu XX; Yin YH; Qu YQ
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3246-3258. PubMed ID: 31364871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 13-gene signature to predict the prognosis and immunotherapy responses of lung squamous cell carcinoma.
    Yang Q; Gong H; Liu J; Ye M; Zou W; Li H
    Sci Rep; 2022 Aug; 12(1):13646. PubMed ID: 35953696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of 17 mRNAs and a miRNA as an integrated prognostic signature for lung squamous cell carcinoma.
    Zhang J; Bing Z; Yan P; Tian J; Shi X; Wang Y; Yang K
    J Gene Med; 2019 Aug; 21(8):e3105. PubMed ID: 31215090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the Role and Regulation Mechanism of hsa-miR-147b in Lung Squamous Cell Carcinoma Based on The Cancer Genome Atlas Database.
    Ke D; Guo Q; Fan TY; Xiao X
    Cancer Biother Radiopharm; 2021 Apr; 36(3):280-291. PubMed ID: 33112657
    [No Abstract]   [Full Text] [Related]  

  • 12. A Systematic Analysis of Dysregulated Long Non-Coding RNAs/microRNAs/mRNAs in Lung Squamous Cell Carcinoma.
    Zhang TJ; Cao JS; Li Q; An GS; Ni JH; Jia HT; Li SY
    Am J Med Sci; 2020 Dec; 360(6):701-710. PubMed ID: 33012486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exostosin1 as a novel prognostic and predictive biomarker for squamous cell lung carcinoma: A study based on bioinformatics analysis.
    Wu D; Huo C; Jiang S; Huang Y; Fang X; Liu J; Yang M; Ren J; Xu B; Liu Y
    Cancer Med; 2021 Apr; 10(8):2787-2801. PubMed ID: 33314711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical value of miR-182-5p in lung squamous cell carcinoma: a study combining data from TCGA, GEO, and RT-qPCR validation.
    Luo J; Shi K; Yin SY; Tang RX; Chen WJ; Huang LZ; Gan TQ; Cai ZW; Chen G
    World J Surg Oncol; 2018 Apr; 16(1):76. PubMed ID: 29636077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA damage repair gene signature model for predicting prognosis and chemotherapy outcomes in lung squamous cell carcinoma.
    Wang X; Huang Z; Li L; Wang G; Dong L; Li Q; Yuan J; Li Y
    BMC Cancer; 2022 Aug; 22(1):866. PubMed ID: 35941578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and validation of an individualized prognostic signature of lung squamous cell carcinoma based on ferroptosis-related genes.
    Diao X; Guo C; Liu L; Wang G; Li S
    Thorac Cancer; 2021 Dec; 12(23):3236-3247. PubMed ID: 34672420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A robust signature associated with patient prognosis and tumor immune microenvironment based on immune-related genes in lung squamous cell carcinoma.
    Zhou H; Zhang H; Shi M; Wang J; Huang Z; Shi J
    Int Immunopharmacol; 2020 Nov; 88():106856. PubMed ID: 32777677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genes whose expressions in the primary lung squamous cell carcinoma are able to accurately predict the progression of metastasis through lymphatic system, inferred from a bioinformatics analyses.
    Khashei Varnamkhasti K; Moghanibashi M; Naeimi S
    Sci Rep; 2023 Apr; 13(1):6733. PubMed ID: 37185598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer.
    Zhang W; Zhang Q; Che L; Xie Z; Cai X; Gong L; Li Z; Liu D; Liu S
    BMC Cancer; 2022 Mar; 22(1):299. PubMed ID: 35313857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune signature of T follicular helper cells predicts clinical prognostic and therapeutic impact in lung squamous cell carcinoma.
    Xu F; Zhang H; Chen J; Lin L; Chen Y
    Int Immunopharmacol; 2020 Apr; 81():105932. PubMed ID: 31836430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.